SNAP25 variant I67N: synaptic phenotypes, drug response and proteome changes in human neurons
Brain · 2025
DOI: 10.1093/brain/awaf119 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, 2025. Verfasst von Maiken Østergaard und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, University of Copenhagen, Copenhagen N 2200, Denmark. Hauptthemen laut MEDLINE: Neurons, Synaptosomal-Associated Protein 25, Proteome, Synapses. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: Lundbeck Foundation, Novo Nordisk Foundation.
Abstract (Originalsprache)
SNAREopathies constitute a group of severe genetic neurodevelopmental disorders caused by de novo variants that disturb the synaptic release machinery. These neurodevelopmental disorders comprise highly diverse clinical phenotypes, usually including developmental delay, epilepsy, intellectual disability and sometimes autism spectrum disorder. Despite major progress in genetic testing, current treatments are limited to symptom-directed therapies. There is an urgent need to establish human experimental systems that improve translatability and help develop personalized mechanism-based treatment strategies. Here, we generated CRISPR/Cas9-engineered human-induced pluripotent stem-cell (hiPSC) lines carrying the pathogenic variant I67N in the SNAREopathy gene SNAP25. Using fast forward NGN2 (NEUROG2)-dependent programming into forebrain glutamatergic neurons, we examined synaptic phenotypes using electrophysiology and immunostaining, as well as protein changes by means of proteomics. The variant did not affect passive or active electrical properties, but caused changes in synaptic transmission, including reduced evoked and spontaneous release, decreased synaptic vesicle release probability and consequential changes in short-term plasticity towards facilitation. These phenotypes were distinct from those of human neurons differentiated from hiPSCs originating from a patient carrying the V48F variant, which displayed an increase in spontaneous release. The I67N variant phenotype could be ameliorated by the clinically approved K+-channel blocker 4-aminopyridine. Proteomic analysis of hiPSC-derived neurons revealed a significant enrichment in downregulated synaptic proteins (e.g. CALB1, SCN2A, LRRC4B, PPFIA2). Our study demonstrates the use of hiPSC-based models of neurodevelopmental disorders to identify disease mechanisms and to suggest personalized treatment options directly targeting specific synaptic defects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience, University of Copenhagen, Copenhagen N 2200, Denmark.
- Department of Veterinary and Animal Sciences, University of Copenhagen, 1870 Frederiksberg C, Denmark.
- Department of Pediatrics, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115, USA.
- Department of Epilepsy Genetics and Personalized Medicine, Danish Epilepsy Centre, Filadelfia, Dianalund 4293, Denmark.
- Department for Regional Health Research, University of Southern Denmark, Odense 5230, Denmark.
- Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense 5230, Denmark.
ORCID-Profile: Rikke S Møller, Kristine Freude, Matthijs Verhage, Jakob Balslev Sørensen
Förderung
- Lundbeck Foundation
- Novo Nordisk Foundation
Zitieren
APA
Østergaard, M., Barbagallo, P., Frederiksen, H. R. S., Chung, W. K., Møller, R. S., Larsen, M. R., Freude, K., Verhage, M., & Sørensen, J. B. (2025). SNAP25 variant I67N: synaptic phenotypes, drug response and proteome changes in human neurons. Brain. https://doi.org/10.1093/brain/awaf119
Vancouver
Østergaard M, Barbagallo P, Frederiksen HRS, Chung WK, Møller RS, Larsen MR, et al. SNAP25 variant I67N: synaptic phenotypes, drug response and proteome changes in human neurons. Brain. 2025. doi:10.1093/brain/awaf119
BibTeX
@article{stergaard2025,
author = {Østergaard, Maiken and Barbagallo, Paola and Frederiksen, Henriette Reventlow S and Chung, Wendy K and Møller, Rikke S and Larsen, Martin Røssel and Freude, Kristine and Verhage, Matthijs and Sørensen, Jakob Balslev},
title = {SNAP25 variant I67N: synaptic phenotypes, drug response and proteome changes in human neurons},
journal = {Brain},
year = {2025},
doi = {10.1093/brain/awaf119}
}
EUVIMED